Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Medico Intercontinental Ltd published its audited financial results for Q4 and full year ended March 31, 2026. Standalone total income was Rs 1,655.31 lakhs for Q4 and Rs 5,680.62 lakhs for FY, with standalone net profit after tax of Rs 53.31 lakhs (Q4) and Rs 256.58 lakhs (FY). Basic EPS stood at Rs 0.42 for Q4 and Rs 2.18 for FY on standalone basis. However, consolidated results showed a different picture with consolidated net loss of Rs 233.25 lakhs for Q4 and Rs 1,098.04 lakhs for FY, with consolidated EPS of Rs -0.65 (Q4) and Rs -3.20 (FY). The results were reviewed by the Audit Committee and approved by the Board of Directors on May 22, 2026, in compliance with SEBI LODR regulations.
Standalone operations remain profitable, but the significant consolidated losses suggest problems in subsidiary or group-level entities. Shareholders should note the wide divergence between standalone and consolidated performance, which may indicate impairment charges, subsidiary losses, or inter-company transactions affecting group profitability.